Logo image of ACR

ACRES COMMERCIAL REALTY CORP (ACR) Stock Fundamental Analysis

USA - NYSE:ACR - US00489Q1022 - REIT

21.13 USD
-0.13 (-0.61%)
Last: 9/23/2025, 6:40:00 PM
Fundamental Rating

3

Overall ACR gets a fundamental rating of 3 out of 10. We evaluated ACR against 67 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. ACR has a medium profitability rating, but doesn't score so well on its financial health evaluation. ACR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ACR had negative earnings in the past year.
ACR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACR reported negative net income in multiple years.
In the past 5 years ACR always reported a positive cash flow from operatings.
ACR Yearly Net Income VS EBIT VS OCF VS FCFACR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.02%, ACR is doing worse than 61.19% of the companies in the same industry.
ACR's Return On Equity of 0.08% is on the low side compared to the rest of the industry. ACR is outperformed by 61.19% of its industry peers.
The Return On Invested Capital of ACR (0.57%) is better than 68.66% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACR is in line with the industry average of 1.28%.
The 3 year average ROIC (0.53%) for ACR is below the current ROIC(0.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.02%
ROE 0.08%
ROIC 0.57%
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.53%
ROIC(5y)N/A
ACR Yearly ROA, ROE, ROICACR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Profit Margin of ACR (0.18%) is worse than 61.19% of its industry peers.
In the last couple of years the Profit Margin of ACR has declined.
The Operating Margin of ACR (6.47%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ACR has declined.
With an excellent Gross Margin value of 42.19%, ACR belongs to the best of the industry, outperforming 83.58% of the companies in the same industry.
ACR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.47%
PM (TTM) 0.18%
GM 42.19%
OM growth 3Y-46.25%
OM growth 5Y-26.58%
PM growth 3Y-34.18%
PM growth 5Y-23.68%
GM growth 3Y-1.09%
GM growth 5Y1.39%
ACR Yearly Profit, Operating, Gross MarginsACR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACR is destroying value.
Compared to 1 year ago, ACR has less shares outstanding
Compared to 5 years ago, ACR has less shares outstanding
Compared to 1 year ago, ACR has an improved debt to assets ratio.
ACR Yearly Shares OutstandingACR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACR Yearly Total Debt VS Total AssetsACR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of -0.46, we must say that ACR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ACR (-0.46) is worse than 62.69% of its industry peers.
ACR has a Debt/Equity ratio of 2.78. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ACR (2.78) is better than 73.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF N/A
Altman-Z -0.46
ROIC/WACC0.08
WACC6.92%
ACR Yearly LT Debt VS Equity VS FCFACR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

ACR has a Current Ratio of 0.31. This is a bad value and indicates that ACR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ACR (0.31) is comparable to the rest of the industry.
ACR has a Quick Ratio of 0.31. This is a bad value and indicates that ACR is not financially healthy enough and could expect problems in meeting its short term obligations.
ACR has a Quick ratio (0.31) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
ACR Yearly Current Assets VS Current LiabilitesACR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

The earnings per share for ACR have decreased strongly by -105.13% in the last year.
The earnings per share for ACR have been decreasing by -15.41% on average. This is quite bad
Looking at the last year, ACR shows a very negative growth in Revenue. The Revenue has decreased by -15.89% in the last year.
Measured over the past years, ACR shows a small growth in Revenue. The Revenue has been growing by 6.60% on average per year.
EPS 1Y (TTM)-105.13%
EPS 3Y-14.58%
EPS 5Y-15.41%
EPS Q2Q%-92.16%
Revenue 1Y (TTM)-15.89%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%4.48%

3.2 Future

ACR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.35% yearly.
Based on estimates for the next years, ACR will show a small growth in Revenue. The Revenue will grow by 1.26% on average per year.
EPS Next Y-36.42%
EPS Next 2Y3.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.69%
Revenue Next 2Y1.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACR Yearly Revenue VS EstimatesACR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100M 200M
ACR Yearly EPS VS EstimatesACR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACR. In the last year negative earnings were reported.
ACR is valuated correctly with a Price/Forward Earnings ratio of 14.23.
ACR's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.87. ACR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 14.23
ACR Price Earnings VS Forward Price EarningsACR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACR is valued cheaper than 85.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 56.72
ACR Per share dataACR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.35%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACRES COMMERCIAL REALTY CORP

NYSE:ACR (9/23/2025, 6:40:00 PM)

21.13

-0.13 (-0.61%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners41.79%
Inst Owner Change18.67%
Ins Owners3.47%
Ins Owner Change-0.12%
Market Cap157.00M
Analysts76.67
Price Target23.97 (13.44%)
Short Float %3.34%
Short Ratio8.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.58
Dividend Growth(5Y)-6.04%
DP6513.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.78%
Min EPS beat(2)-262.19%
Max EPS beat(2)-77.37%
EPS beat(4)1
Avg EPS beat(4)-74.95%
Min EPS beat(4)-262.19%
Max EPS beat(4)79.34%
EPS beat(8)4
Avg EPS beat(8)-35.48%
EPS beat(12)8
Avg EPS beat(12)-15.84%
EPS beat(16)10
Avg EPS beat(16)-25.89%
Revenue beat(2)1
Avg Revenue beat(2)-8.17%
Min Revenue beat(2)-22.92%
Max Revenue beat(2)6.58%
Revenue beat(4)2
Avg Revenue beat(4)-3.69%
Min Revenue beat(4)-22.92%
Max Revenue beat(4)6.58%
Revenue beat(8)4
Avg Revenue beat(8)0.67%
Revenue beat(12)8
Avg Revenue beat(12)30.82%
Revenue beat(16)12
Avg Revenue beat(16)55.98%
PT rev (1m)6.82%
PT rev (3m)6.82%
EPS NQ rev (1m)-71.23%
EPS NQ rev (3m)-53.33%
EPS NY rev (1m)0%
EPS NY rev (3m)68.27%
Revenue NQ rev (1m)-0.45%
Revenue NQ rev (3m)9.67%
Revenue NY rev (1m)-3.36%
Revenue NY rev (3m)3.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.23
P/S 0.87
P/FCF N/A
P/OCF 9.46
P/B 0.37
P/tB 0.38
EV/EBITDA 56.72
EPS(TTM)-0.1
EYN/A
EPS(NY)1.48
Fwd EY7.03%
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)2.23
OCFY10.57%
SpS24.3
BVpS57.24
TBVpS56.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.08%
ROCE 0.72%
ROIC 0.57%
ROICexc 0.58%
ROICexgc 0.59%
OM 6.47%
PM (TTM) 0.18%
GM 42.19%
FCFM N/A
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.53%
ROIC(5y)N/A
ROICexc(3y)0.55%
ROICexc(5y)N/A
ROICexgc(3y)0.55%
ROICexgc(5y)N/A
ROCE(3y)0.67%
ROCE(5y)N/A
ROICexcg growth 3Y-27.63%
ROICexcg growth 5Y-15.6%
ROICexc growth 3Y-27.72%
ROICexc growth 5Y-15.71%
OM growth 3Y-46.25%
OM growth 5Y-26.58%
PM growth 3Y-34.18%
PM growth 5Y-23.68%
GM growth 3Y-1.09%
GM growth 5Y1.39%
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF N/A
Debt/EBITDA 47.07
Cap/Depr 157%
Cap/Sales 11.68%
Interest Coverage 0.12
Cash Conversion 66.05%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z -0.46
F-Score6
WACC6.92%
ROIC/WACC0.08
Cap/Depr(3y)766.24%
Cap/Depr(5y)459.83%
Cap/Sales(3y)30.67%
Cap/Sales(5y)18.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.13%
EPS 3Y-14.58%
EPS 5Y-15.41%
EPS Q2Q%-92.16%
EPS Next Y-36.42%
EPS Next 2Y3.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.89%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%4.48%
Revenue Next Year-0.69%
Revenue Next 2Y1.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.43%
EBIT growth 3Y-34.93%
EBIT growth 5Y-21.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-125.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.82%
OCF growth 3Y-21.84%
OCF growth 5Y-14.85%